^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Abegrin (etaracizumab)

i
Other names: MEDI-522
Associations
News
Trials
Company:
AstraZeneca
Drug class:
αvβ3 integrin antagonist
Associations
News
Trials